Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA sets review date for Ironshore Pharmaceuticals’ ADHD drug HLD200 Ironshore Pharmaceuticals & Development, a subsidiary of Highland Therapeutics, has reached a significant milestone with the U.S. Food… bypharmanewsdailyJuly 15, 2018